Rob Dillard

DocwireNews

UPDATED 5-26-20: See Perspective from Dr. Payal Kohli at the end of the article.Clinicians should be cognizant of the potential for recovered COVID-19 patients presenting&nbsp; neuropsychiatric side effects such as <a href="https://www.docwirenews.com/docwire-pick/home-page-picks/arthritis-medication-depressive-symptoms/">depression</a>, anxiety, and post-traumatic stress disorder (<a href="https://www.docwirenews.com/home-page-editor-picks/gunshot-wound-survivors-suffer-increased-rates-ptsd-unemployment-substanceabuse/">PTSD</a>) in the longer term, according to the findings of a <a href="https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30203-0/fulltext">new study</a> published in The Lancet Psychiatry.In this systematic review and meta-analysis, researchers combed MEDLINE, Embase, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature databases from inception until March 18, 2020, as well as medRxiv, bioRxiv, and PsyArXiv between Jan 1, 2020, and April 10, 2020. They focused on studies or preprints that reported on patients with a confirmed diagnosis of SARS coronavirus, MERS coronavirus, or COVID-19 that presented with neuropsychiatric irregularities. The study endpoints were defined as psychiatric signs or symptoms; symptom severity; diagnoses based on ICD-10, DSM-IV, or the Chinese Classification of Mental Disorders (third edition) or psychometric scales; quality of life; and employment. In total, the investigators included 65 peer-reviewed studies and seven preprints comprised 3,559 coronavirus cases in their analysis.According to the results of the review, common symptoms among patients admitted to hospital for SARS or MERS included confusion (36 [27.9%; 95% CI 20.5 to 36.0), depression (42 [32.6%; 95% CI, 24.7 to 40.9), anxiety (46 [35.7%; 95% CI, 27.6 to 44.2), impaired memory (44 [34.1%; 26.2 to 42.5] of 129), and insomnia (54 [41.9%; 22.5 to 50.5] of 129).Regarding COVID-19, the researchers observed evidence of delirium/confusion data for patients with COVID-19 were examined (including preprint data), altered consciousness. Following recovery, the researchers observed that 33% of 45 patients with COVID-19 who were evaluated presented with dysexecutive syndrome in one study. The investigators noted that at the time of writing this analysis, there were two reports of hypoxic encephalopathy and one report of encephalitis in <a href="https://www.docwirenews.com/home-page-editor-picks/the-covid-19-pandemic-us-death-toll-exceeds-90000-vaccine-trial-shows-promising-early-results-and-more/">SARS-CoV-2</a> patients.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
[Articles] Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic <a href="https://t.co/5yeYj3dv4F">https://t.co/5yeYj3dv4F</a> <a href="https://t.co/mJoIXFDHFW">pic.twitter.com/mJoIXFDHFW</a>
&mdash; Dr Christian Schulz-Quach (he/him) (@Dr_SchulzQuach) <a href="https://twitter.com/Dr_SchulzQuach/status/1262512680281104384?ref_src=twsrc%5Etfw">May 18, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;The authors wrote in conclusion that &ldquo;although there are many ways in which mental health might be adversely affected by a pandemic, this review suggests, first, that most people do not suffer from a psychiatric disorder following coronavirus infection, and second, that so far there is little to suggest that common neuropsychiatric complications beyond short-term delirium are a feature.&rdquo;They added that clinicians &ldquo;must be aware of the possibility of depression, anxiety, fatigue, post-traumatic stress disorder, and rarer neuropsychiatric syndromes in the aftermath. The quality of studies to date has been variable, and ongoing surveillance is essential.&rdquo;<h2>Perspective from Payal Kohli, MD</h2>Flattening the curve of the medical morbidity and mortality from the pandemic has been effective thus far with the extreme lockdown and social distancing measures we have enacted. &nbsp;But, as Americans contract and recover from the virus and we start to transition back to &ldquo;normal&rdquo; life again, we will have to consider the long-term psychological impact the past several weeks have had. &nbsp;This includes those who directly contract the virus, the healthcare workers who have cared for them as well was the others in society.This systematic review and meta-analysis is key in highlighting that the virus itself can result in short-term delirium and also raises the possibility that there may be rarer neuropsychiatric syndromes in the aftermath. &nbsp;Studies have shown that direct neuronal inflammation may be responsible for the anosmia and aguesia that has been observed as a presenting symptom in this infection. &nbsp;It remains to be seen whether such inflammation could also result in neuropsychiatric symptoms. &nbsp; Additional longer term follow-up will be necessary to see whether late-presenting neuropsychiatric effects may emerge in the aftermath of this virus.With respect to healthcare workers who have cared for patients with COVID-19, data is more limited. &nbsp;From studies of 2003 SARS epidemic, it has been reported that moderate to severe depression occurs in 23% of hospital employees three years later, with all combine all mental health issues occurring in up to 33% of hospital employees. &nbsp;The anticipated&nbsp;burden of the COVID-19 epidemic is expected to be at least as much, if not greater.For those not infected by&nbsp;the virus directly or those caring for the&nbsp;infected,&nbsp;the social distancing has been certainly shown to impose a psychological toll with a growing incidence of loneliness, substance abuse and related mental&nbsp;health concerns, such as anxiety and depression.To&nbsp;truly understand the&nbsp;psychological&nbsp;impact of&nbsp;this pandemic, the totality of the mental health fallout must be considered.&ndash;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic <a href="https://t.co/bBefDNdgyF">https://t.co/bBefDNdgyF</a>
&mdash; Kelly A. Hogan Ph.D. (@Loose_Lab_Rat) <a href="https://twitter.com/Loose_Lab_Rat/status/1262813208726974464?ref_src=twsrc%5Etfw">May 19, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic &ndash; The Lancet Psychiatry <a href="https://t.co/3dh7juaHXh">https://t.co/3dh7juaHXh</a>
&mdash; Prof Marios Adamou OBE (@DrMariosAdamou) <a href="https://twitter.com/DrMariosAdamou/status/1263156818286608384?ref_src=twsrc%5Etfw">May 20, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&nbsp;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Clinicians Must Be Aware of COVID-19 Patients Possibly Presenting with Neuropsychiatric Disorders Such as Depression, and PTSD Following Recovery (Updated)

Depression

UPDATED 5-26-20: See Perspective from Dr. Payal Kohli at the end of the article. ...

Clinicians Must Be Aware of COVID-19 Patients Possibly Presenting with Neuropsychiatric Disorders

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe